CareDx (CDNA) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. S
10. COF

Go back to CareDx (CDNA) Tops Q2 EPS by 3c

CareDx Reports Second Quarter Results

August 9, 2018 4:01 PM EDT

AlloSure launch momentum drives 48% revenue growth

BRISBANE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today reported financial results for the second quarter ended June 30, 2018.

Recent highlights:

Accelerated AlloSure penetration in key kidney transplant centers Less than 9 months into AlloSure launch, CareDx supports approximately 1% of the U.S. living kidney transplant patient populationAs of June 30, 2018, 76 U.S. transplant centers have... More